Gleck Pharma (OPC) Private Limited
Gleck Pharma (OPC) Private Limited is a Private Indian company incorporated in 2019 and based in Delhi, India. Gleck Pharma (OPC) Private Limited operates in Pharmaceuticals & Chemicals (NIC 24239) with authorized capital of —. RegisterKaro's Compliance Health Score for the company is 30/100 (grade F), reflecting a weak compliance posture.
Explore the complete profile of Gleck Pharma (opc) Private Limited, including financials and company filings, contact details, and much more on Tracxn.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Gleck Pharma (OPC) Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +17d | filed |
| MGT-7 | FY2024-25 | 20 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 25 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 24 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Gleck Pharma (OPC) Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 417875598 | HDFC Bank Ltd(Bank) | ₹7.01 Cr | 27 Jan 2020 | Open |
| 809656456 | Axis Bank Ltd(Bank) | ₹2.78 Cr | 19 Sep 2022 | Open |
| 761964727 | ICICI Bank Ltd(Bank) | ₹4.90 Cr | 27 Jan 2023 | Open |
| 398163367 | ICICI Bank Ltd(Bank) | ₹12.04 Cr | 04 Jul 2022 | Open |
| 119628217 | HDFC Bank Ltd(Bank) | ₹9.90 Cr | 12 Mar 2021 | Open |
Charge IDs, lenders & amounts for Gleck Pharma (OPC) Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
Locked| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| FY2024-25 | ₹8.05 Cr | ₹98.34 L | ₹3.46 Cr | ₹8.69 Cr | 239 |
| FY2023-24 | ₹6.69 Cr | ₹1.02 Cr | ₹6.23 Cr | ₹9.85 Cr | 253 |
| FY2022-23 | ₹5.28 Cr | ₹72.34 L | ₹1.99 Cr | ₹6.03 Cr | 35 |
| FY2021-22 | ₹4.76 Cr | ₹62.36 L | ₹4.06 Cr | ₹5.81 Cr | 97 |
Audited financials & ratios for Gleck Pharma (OPC) Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Detailed Financials
Locked| Line item | FY2024-25 | FY2023-24 | FY2022-23 | FY2021-22 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ₹8.05 Cr | ₹6.69 Cr | ₹5.28 Cr | ₹4.76 Cr |
| Other income | ₹17.24 L | ₹13.41 L | ₹10.50 L | ₹10.74 L |
| Total income | ₹8.23 Cr | ₹6.82 Cr | ₹5.39 Cr | ₹4.87 Cr |
| Total expenses | ₹6.97 Cr | ₹5.52 Cr | ₹4.46 Cr | ₹4.07 Cr |
| Profit before tax | ₹1.28 Cr | ₹1.32 Cr | ₹94.04 L | ₹81.06 L |
| Profit / (Loss) after tax | ₹98.34 L | ₹1.02 Cr | ₹72.34 L | ₹62.36 L |
| Balance sheet | ||||
| Equity / Net worth | ₹3.46 Cr | ₹6.23 Cr | ₹1.99 Cr | ₹4.06 Cr |
| Borrowings | ₹2.80 Cr | ₹92.91 L | ₹1.47 Cr | ₹44.37 L |
| Current liabilities | ₹2.17 Cr | ₹1.90 Cr | ₹2.32 Cr | ₹78.02 L |
| Total liabilities | ₹5.22 Cr | ₹3.62 Cr | ₹4.04 Cr | ₹1.75 Cr |
| Current assets | ₹5.04 Cr | ₹4.13 Cr | ₹2.87 Cr | ₹2.51 Cr |
| Cash & equivalents | ₹1.38 Cr | ₹1.20 Cr | ₹59.71 L | ₹51.64 L |
| Total assets | ₹8.69 Cr | ₹9.85 Cr | ₹6.03 Cr | ₹5.81 Cr |
| Employees | 239 | 253 | 35 | 97 |
Audited financials & ratios for Gleck Pharma (OPC) Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹8.05 Cr | +13.1% | +4.7% | +14.0% |
| Profit after Tax | ₹98.34 L | +2.2% | +17.2% | +1.2% |
| Net Worth | ₹3.46 Cr | -0.9% | +10.5% | +18.1% |
| Employees | 239 | -0.1% | +1.8% | +13.9% |
Audited financials & ratios for Gleck Pharma (OPC) Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
Locked| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| FY2024-25 | ₹8.05 Cr | ₹98.34 L | +12.21% | -10.24% | +28.38% | +11.32% | 0.81 | ₹3.37 L |
| FY2023-24 | ₹6.69 Cr | ₹1.02 Cr | +15.19% | +38.15% | +16.31% | +10.32% | 0.15 | ₹2.64 L |
| FY2022-23 | ₹5.28 Cr | ₹72.34 L | +13.69% | +22.10% | +36.27% | +12.00% | 0.74 | ₹15.09 L |
| FY2021-22 | ₹4.76 Cr | ₹62.36 L | +13.10% | +7.45% | +15.36% | +10.73% | 0.11 | ₹4.91 L |
Audited financials & ratios for Gleck Pharma (OPC) Private Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 1,04,33,446 | 81.98% |
| Institutional Investors | 3 | 7,24,717 | 5.69% |
| Public & Others | 37 | 15,67,887 | 12.32% |
Promoter, institutional & public holding for Gleck Pharma (OPC) Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
122 peersExternal data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.